Form S-1/A CATALYST BIOSCIENCES,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Catalyst Biosciences (CBIO) Prices Common Stock and Warrant Offering for Gross Proceeds of $18M
April 7, 2017 8:40 AM EDTCatalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced the pricing of an underwritten public offering of units for gross proceeds of $18 million, prior to deducting underwriting discounts and commissions and offering expenses payable by Catalyst.
The offering is comprised of Class A Units, priced at a public offering price of $5.00 per unit, with each unit consisting of one share of common stock and a five-year warrant (each, a warrant) to purchase one-half share of common stock with an... More
Catalyst Biosciences (CBIO) Set to Open Lower
April 7, 2017 6:46 AM EDTCatalyst Biosciences (NASDAQ: CBIO) was set to open sharply lower Friday morning following an effective notice from the SEC regarding its recent S-1.
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Notice of EffectivenessEffectiveness Date:April 6, 2017 5:00 P.M.Form:S-1CIK:0001124105Company Name:CATALYST BIOSCIENCES, INC.File Number:333-216663... More